Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-658 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
filingDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863df0e633197f494958ad4754ce5d4f |
publicationDate |
2017-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170124098-A |
titleOfInvention |
Multi-detection Biosensor of Alzheimer's Disease Based on Rayleigh Scattering with Colorimetric Assay and Multi-detecting Method Using The Same |
abstract |
The present invention relates to a nanoplasmonic sensor based on Alzheimer's disease markers such as beta amyloid 40, beta amyloid 42, tau protein-recognizing antibody or aptamer-bound gold nanoparticles, The present invention relates to a multi-detection method of Alzheimer's disease using a colorimetric assay. The present invention is a simple diagnostic method using blood, and it is possible to perform simultaneous multiple detection on several oncological markers and the sensitivity of diagnosis is improved by using a chaotropic solvent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220052521-A |
priorityDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |